Nomura Holdings’s Cano Health, Inc. CANO Stock Holding History

Nomura Holdings’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-750	Closed	-$651K	–	1800
2022 Q3	$651K	Buy	+750	New	+$470K	﹤0.01%	1055

Other funds holding CANO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nomura Holdings's CANO Position: Q3 2023 in Review

Nomura Holdings sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 345 shares — an estimated $28.4K sold.

Nomura Holdings first reported a position in CANO in Q3 2020 and held it in 6 quarters. The position peaked at $20.8M in Q3 2020. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

Nomura Holdings reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
Nomura Holdings sold 345 Cano Health, Inc. shares in Q3 2023, an estimated $28.4K.
Nomura Holdings first reported a position in Cano Health, Inc. in Q3 2020 and held it in 6 quarters.
Nomura Holdings's Cano Health, Inc. position peaked at $20.8M in Q3 2020.
134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Nomura Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.